Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
Loss of myotubularin function results in T-tubule disorganization in zebrafish
and human myotubular myopathy.
Authors
Dowling JJ, Vreede AP, Low SE, Gibbs EM, Kuwada JY, Bonnemann CG, Feldman EL
Submitted By
Eva Feldman on 2/8/2009
Status
Published
Journal
PLoS genetics
Year
2009
Date Published
2/1/2009
Volume : Pages
5(2) : e1000372
PubMed Reference
19197364
Abstract
Myotubularin is a lipid phosphatase implicated in endosomal trafficking in
vitro, but with an unknown function in vivo. Mutations in myotubularin cause
myotubular myopathy, a devastating congenital myopathy with unclear pathogenesis
and no current therapies. Myotubular myopathy was the first described of a
growing list of conditions caused by mutations in proteins implicated in
membrane trafficking. To advance the understanding of myotubularin function and
disease pathogenesis, we have created a zebrafish model of myotubular myopathy
using morpholino antisense technology. Zebrafish with reduced levels of
myotubularin have significantly impaired motor function and obvious
histopathologic changes in their muscle. These changes include abnormally shaped
and positioned nuclei and myofiber hypotrophy. These findings are consistent
with those observed in the human disease. We demonstrate for the first time that
myotubularin functions to regulate PI3P levels in a vertebrate in vivo, and that
homologous myotubularin-related proteins can functionally compensate for the
loss of myotubularin. Finally, we identify abnormalities in the tubulo-reticular
network in muscle from myotubularin zebrafish morphants and correlate these
changes with abnormalities in T-tubule organization in biopsies from patients
with myotubular myopathy. In all, we have generated a new model of myotubular
myopathy and employed this model to uncover a novel function for myotubularin
and a new pathomechanism for the human disease that may explain the weakness
associated with the condition (defective excitation-contraction coupling). In
addition, our findings of tubuloreticular abnormalities and defective
excitation-contraction coupling mechanistically link myotubular myopathy with
several other inherited muscle diseases, most notably those due to ryanodine
receptor mutations. Based on our findings, we speculate that congenital
myopathies, usually considered entities with similar clinical features but very
disparate pathomechanisms, may at their root be disorders of calcium
homeostasis.
Investigators with authorship
Name
Institution
Eva Feldman
University of Michigan
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!